Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.39 |
| ▸ | CYP3A4 | P08684 | 1/20 | 0.39 |
| ▸ | ESR1 | P03372 | 4/20 | 0.33 |
| ▸ | ESR2 | Q92731 | 4/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | POLB | P06746 | 1/20 | 0.31 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.31 |
| ▸ | ELANE | P08246 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | LMNA | P02545 | 1/20 | 0.31 |
| ▸ | TP53 | P04637 | 1/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.30 |
| ▸ | PSMB8 | P28062 | 1/20 | 0.30 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.30 |
| ▸ | RXFP1 | Q9HBX9 | 1/20 | 0.30 |
| ▸ | MAOA | P21397 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1279637 | 0.85 | CYP3A4 (0.32) | TDP1CYP3A4ALDH1A1TSHRLMNA | |
| SCHEMBL29745774 | 0.85 | CYP3A4 (0.32) | TDP1CYP3A4ALDH1A1HPGDPOLB | |
| SCHEMBL1279461 | 0.85 | CYP3A4 (0.32) | TDP1CYP3A4 | |
| SCHEMBL17584977 | 0.84 | TSHR (0.31) | TSHR | |
| SCHEMBL24718701 | 0.83 | CYP3A4 (0.31) | TDP1CYP3A4 | |
| SCHEMBL17828675 | 0.83 | CYP3A4 (0.31) | TDP1CYP3A4 | |
| SCHEMBL17828682 | 0.83 | CYP3A4 (0.31) | TDP1CYP3A4 | |
| SCHEMBL17617105 | 0.83 | — | — | |
| SCHEMBL887436 | 0.83 | — | — | |
| SCHEMBL18840106 | 0.82 | CYP3A4 (0.30) | TDP1CYP3A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 138 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025039237-A1 | ETHYLENE OLIGOMERIZATION PROCESS | 万华化学集团股份有限公司 | 2025-02-27 | — | — | WO | claimed |
| CN-118847222-A | Preparation method and application of PNP ligand synthetic solution for ethylene selective oligomerization chromium complex catalyst | 大连理工大学 | 2024-10-29 | — | — | CN | claimed |
| CN-115028509-B | Ethylene oligomerization process with enhanced reactivity and reduced polymer formation | 万华化学集团股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-114956939-B | Ethylene oligomerization regulation and control method | 万华化学集团股份有限公司 | 2024-02-02 | — | — | CN | claimed |
| CN-115028508-B | Ethylene tetramerization process with reduced PE (polyethylene) production | 万华化学集团股份有限公司 | 2023-05-26 | — | — | CN | claimed |
| CN-115028509-A | Ethylene oligomerization process with increased reactivity and reduced polymer formation | 万华化学集团股份有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-115028508-A | Ethylene tetramerization process with reduced PE generation amount | 万华化学集团股份有限公司 | 2022-09-09 | — | — | CN | claimed |
| CN-114956939-A | Ethylene oligomerization regulation and control method | 万华化学集团股份有限公司 | 2022-08-30 | — | — | CN | claimed |
| CN-109678681-A | A method of preparing halogenated biphenyl | 南京大学 | 2019-04-26 | — | — | CN | claimed |
| EP-4399263-B1 | HEAVY OLIGOMER COMPOSITIONS OF A SELECTIVE 1-HEXENE AND 1-OCTENE CATALYST | CHEVRON PHILLIPS CHEMICAL CO LP (US) | 2026-05-06 | — | — | EP | disclosed |
| EP-4729593-A2 | HEAVY OLIGOMER COMPOSITIONS OF A SELECTIVE I-HEXENE AND I-OCTENE CATALYST | Chevron Phillips Chemical Company LP (US) | 2026-04-22 | — | — | EP | disclosed |
| US-20260061408-A1 | CATALYST COMPOSITION FOR OLEFIN OLIGOMERIZATION | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2026-03-05 | — | — | US | disclosed |
| US-12364976-B2 | Catalyst systems suitable for the tetramerization of ethylene and methods of using the same | SAUDI ARABIAN OIL COMPANY (SA) | 2025-07-22 | — | — | US | disclosed |
| EP-3268129-B1 | OLEFIN OLIGOMERISATION PROCESS WITH A CATALYST COMPRISING A CHROMIUM COMPLEX WITH A PHOSPHACYCLE-CONTAINING LIGAND | DOW GLOBAL TECHNOLOGIES LLC (US) | 2025-06-18 | — | — | EP | disclosed |
| US-20140228594-A1 | METHOD FOR PURIFYING A CRUDE PNPNH COMPOUND | LINDE AG (DE) | 2014-08-14 | — | — | US | disclosed |
| US-20120172645-A1 | Olefin Oligomerization catalysts and Methods of Making and Using Same | CHEVRON PHILLIPS CHEMICAL COMPANY LP (US) | 2012-07-05 | — | — | US | disclosed |
| WO-2011095272-A1 | METHOD FOR DEACTIVATION OF A CATALYST | LINDE AKTIENGESELLSCHAFT (DE) | 2011-08-11 | — | — | WO | disclosed |
| EP-2354113-A1 | Method for deactivation of a catalyst | Linde AG (DE) | 2011-08-10 | — | — | EP | disclosed |
| US-7285607-B2 | Polymerisation of olefinic compounds | SASOL, CHEMICAL INDUSTRIES, LIMITED (ZA) | 2007-10-23 | — | — | US | disclosed |
| US-20060020091-A1 | Polymerisation of olefinic compounds | SASOL CHEMICAL INDUSTRIES LIMITED (ZA) | 2006-01-26 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260061408-A1 | CATALYST COMPOSITION FOR OLEFIN OLIGOMERIZATION | CHRND, C5, SCO2 | TDP1 445/4885CYP3A4 1662/4885ESR1 546/4885 |
| US-20120172645-A1 | Olefin Oligomerization catalysts and Methods of Making and Using Same | COG7, COG8, COG4 | TDP1 391/4885CYP3A4 1261/4885ESR1 3001/4885 |
| US-20140228594-A1 | METHOD FOR PURIFYING A CRUDE PNPNH COMPOUND | PNP, C1R, PKN2 | TDP1 802/4885CYP3A4 1441/4885ESR1 4690/4885 |
| US-12364976-B2 | Catalyst systems suitable for the tetramerization of ethylene and methods of using the same | C5, C9, C1S | TDP1 1504/4885CYP3A4 139/4885ESR1 21/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.